1
Treating Kidney Donors With Valganciclovir to Reduce Viral Transmission to Recipients
Condition(s): EBV Viremia; CMV Viremia Last Updated: September 18, 2012Enrolling by invitation
55 Clinical Trials for: “Viremia”, Page 1 of 3
Hide Studies Not Seeking New Volunteers
2
BK Treatment Study
Condition(s): BK Viremia Last Updated: October 9, 2012Completed
3
An Open-Label, Study to Treat Patients With Renal Allograft and Polyoma BK Viruria
Condition(s): Viruria; Viremia Last Updated: June 21, 2012Not yet recruiting
4
The Safety, Tolerability and Pharmacokinetic of a Novel Antiviral Drug
Condition(s): BK Virus (BKV) Viremia Last Updated: March 4, 2013Not yet recruiting
5
Yellow Fever Virus Vaccine and Immune Globulin Study
Condition(s): Viremia; Immune Response to Yellow Fever Virus Vaccination Last Updated: December 8, 2008Completed
6
Viral Load in Blood and Lymph Tissues of HIV-Infected Individuals
Condition(s): HIV Infection; Viremia Last Updated: December 22, 2012Recruiting
7
Using mTOR Inhibitors in the Prevention of BK Nephropathy
Condition(s): BK Viremia; BK Nephropathy Last Updated: July 25, 2012Recruiting
8
Tenofovir in Late Pregnancy to Prevent Vertical Transmission of Hepatitis B Virus
Condition(s): Hepatitis B Infection; Chronic Infection; Viremia Last Updated: October 26, 2012Recruiting
9
Nucleoside Analogue Prevent Vertical Transmission of Hepatitis B Virus
Condition(s): Hepatitis B Infection; Chronic Infection; Viremia Last Updated: February 7, 2013Active, not recruiting
10
Genotypic Tropism Testing In Proviral Dna To Guide CCR5 Antagonist Treatment In Subjects With Undetectable HIV-1 Viremia
Condition(s): HIV Last Updated: October 18, 2012Recruiting
11
Induction Related BK Viremia in Renal Transplant Patients
Condition(s): Disease Due to BK Polyomavirus; Transplantation Infection; Disorder Related to Transplantation Last Updated: September 26, 2011Completed
12
BK Viremia After Renal Transplantation
Condition(s): Terminal Renal Failure; BK Virus Infection Last Updated: February 5, 2009Active, not recruiting
13
Reactivation of CMV Infection in Immunocompetent Patients Under Severe Stress
Condition(s): Cytomegalovirus Viraemia; Stress, Physiological; Receptor, Hormonal; Disorder; Other Deficiency of Cell-mediated Immunity Last Updated: August 12, 2011Recruiting
14
Entecavir Intensification for Persistent HBV Viremia in HIV-HBV Infection
Condition(s): HIV Infections; Hepatitis B Last Updated: May 15, 2013Completed
15
Thalidomide for Treatment of Oral and Esophageal Aphthous Ulcers and HIV Viremia in Patients With HIV Infection
Condition(s): HIV Infections; Stomatitis, Aphthous Last Updated: March 30, 2012Completed
16
Patients With Chronic Hepatitis B and Low Viremia Not Receiving Antiviral Therapy
Condition(s): Hepatitis B, Chronic Last Updated: May 21, 2012Recruiting
17
Switching From Protease Inhibitor (PI) to Etravirine in HIV-1 Infected Subjects With Viremia Suppression
Condition(s): HIV Last Updated: October 24, 2012Completed
18
Effect of Switching to Certican® in Viremia of Hepatitis C Virus in Adult Renal Allograft Recipients
Condition(s): Renal Allograft; Hepatitis C Last Updated: March 27, 2013Recruiting
19
Study to Evaluate HIV Viremia and Persistence in Acutely HIV-Infected ARV Naïve Patients Treated With Darunavir/Ritonavir and Etravirine
Condition(s): Acute HIV Infection; HIV Infections Last Updated: March 15, 2013Recruiting
20
Primary Transplant or Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation
Condition(s): Cytomegalovirus Last Updated: January 31, 2013Recruiting
